Across the past 12 months, open-market trades by Organogenesis Holdings insiders totaled $40,093 in purchases (15K shares) and $2.62 million in sales (500K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Alan A. Ades | Director, TenPercentOwner | 51,085,402 | 51,085,402 | 102,170,804 | 47.0% | 13 Jan, 2025 |
| 2 | Albert Erani | TenPercentOwner | 51,585,403 | 0 | 51,585,403 | 23.7% | 14 Nov, 2024 |
| 3 | 2016 Family Trust U/A/D August 12, 2016 Gn | TenPercentOwner | 51,085,403 | 0 | 51,085,403 | 23.5% | 02 Dec, 2024 |
| 4 | Gary S. Gillheeney | President And Ceo | 4,232,087 | 0 | 4,232,087 | 1.9% | 03 Mar, 2026 |
| 5 | Glenn H Nussdorf | Director | 2,565,591 | 0 | 2,565,591 | 1.2% | 18 Dec, 2025 |
| 6 | Patrick Bilbo | Chief Operating Officer | 1,128,312 | 0 | 1,128,312 | 0.5% | 03 Mar, 2026 |
| 7 | Lori Freedman | Chief Admin. And Legal Officer | 1,023,643 | 0 | 1,023,643 | 0.5% | 03 Mar, 2026 |
| 8 | Brian Grow | Chief Commercial Officer | 899,724 | 0 | 899,724 | 0.4% | 03 Mar, 2026 |
| 9 | David Francisco | Chief Financial Officer | 731,312 | 0 | 731,312 | 0.3% | 03 Mar, 2026 |
| 10 | Arthur S Leibowitz | Director | 291,014 | 0 | 291,014 | 0.1% | 11 Mar, 2026 |
| 11 | Robert Cavorsi | Vice President, Strategy | 275,524 | 0 | 275,524 | 0.1% | 03 Mar, 2026 |
| 12 | Prathyusha Duraibabu | Director | 247,047 | 0 | 247,047 | 0.1% | 20 Feb, 2026 |
| 13 | Jon L Giacomin | Director | 241,026 | 0 | 241,026 | 0.1% | 20 Feb, 2026 |
| 14 | Michele Ilene Korfin | Director | 239,073 | 0 | 239,073 | 0.1% | 20 Feb, 2026 |
| 15 | Gilberto Quintero | Director | 239,073 | 0 | 239,073 | 0.1% | 20 Feb, 2026 |
| 16 | Antonio S. Montecalvo | Vice President, Health Policy | 226,238 | 0 | 226,238 | 0.1% | 03 Mar, 2026 |
| 17 | Michael Joseph Driscoll | Director | 225,707 | 0 | 225,707 | 0.1% | 11 Mar, 2026 |
| 18 | Garrett Lustig | Director | 125,742 | 0 | 125,742 | 0.1% | 20 Feb, 2026 |
| 19 | Michael W Katz | TenPercentOwner | 76,382 | 0 | 76,382 | 0.0% | 22 Nov, 2022 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 09 Mar, 2026 | Arthur S Leibowitz | Director | Acquired P | 5,000 | $2.68 | $13.41K | 291,014 | Direct |
| 09 Mar, 2026 | Michael Joseph Driscoll | Director | Acquired P | 10,000 | $2.67 | $26.69K | 225,707 | Direct |
| 18 Feb, 2026 | David Francisco | Chief Financial Officer | Acquired A | 44,040 | $0.00 | $0 | 745,999 | Direct |
| 18 Feb, 2026 | Patrick Bilbo | Chief Operating Officer | Acquired A | 49,102 | $0.00 | $0 | 1,144,687 | Direct |
| 18 Feb, 2026 | Robert Cavorsi | Vice President, Strategy | Acquired A | 16,454 | $0.00 | $0 | 281,711 | Direct |
| 18 Feb, 2026 | Antonio S. Montecalvo | Vice President, Health Policy | Acquired A | 11,330 | $0.00 | $0 | 230,016 | Direct |
| 01 Mar, 2026 | Robert Cavorsi | Vice President, Strategy | Disposed F | 700 | $3.21 | $2.25K | 275,524 | Direct |
| 18 Feb, 2026 | Lori Freedman | Chief Admin. And Legal Officer | Acquired A | 43,212 | $0.00 | $0 | 1,038,054 | Direct |
| 18 Feb, 2026 | Brian Grow | Chief Commercial Officer | Acquired A | 48,818 | $0.00 | $0 | 911,611 | Direct |
| 18 Feb, 2026 | Gary S. Gillheeney | President And Ceo | Acquired A | 188,856 | $0.00 | $0 | 4,323,398 | Direct |
| 18 Feb, 2026 | Robert Cavorsi | Vice President, Strategy | Disposed F | 5,487 | $3.84 | $21.07K | 276,224 | Direct |
| 18 Feb, 2026 | David Francisco | Chief Financial Officer | Disposed F | 14,687 | $3.84 | $56.40K | 731,312 | Direct |
| 18 Feb, 2026 | Gary S. Gillheeney | President And Ceo | Disposed F | 91,311 | $3.84 | $350.63K | 4,232,087 | Direct |
| 18 Feb, 2026 | Antonio S. Montecalvo | Vice President, Health Policy | Disposed F | 3,778 | $3.84 | $14.51K | 226,238 | Direct |
| 18 Feb, 2026 | Brian Grow | Chief Commercial Officer | Disposed F | 11,887 | $3.84 | $45.65K | 899,724 | Direct |
| 18 Feb, 2026 | Lori Freedman | Chief Admin. And Legal Officer | Disposed F | 14,411 | $3.84 | $55.34K | 1,023,643 | Direct |
| 18 Feb, 2026 | Patrick Bilbo | Chief Operating Officer | Disposed F | 16,375 | $3.84 | $62.88K | 1,128,312 | Direct |
| 18 Feb, 2026 | Lori Freedman | Chief Admin. And Legal Officer | Acquired A | 203,125 | $0.00 | $0 | 994,842 | Direct |
| 18 Feb, 2026 | Arthur S Leibowitz | Director | Acquired A | 48,828 | $0.00 | $0 | 286,014 | Direct |
| 18 Feb, 2026 | Jon L Giacomin | Director | Acquired A | 48,828 | $0.00 | $0 | 241,026 | Direct |